NIH/National Institute of Allergies and Infectious Disease (NIAID) is part of the National Institute of Health, funded through theUSA Department of Health and Human Services, a cabinet level agency. NIAID has been in existence for over 50 years and its primary role is to conduct, support and find effective treatments for infectioius, immunological and allergic diseases. Some of its efforts are conducted in-house, but a significant amount of research funds are awarded to scientists, labs and universities to accomplish NIAID goals. NIAID credits itself with developing new vaccines, new therapies and new diagnostic tests which have aided millions of people.
Some content from Wikipedia, licensed under CC BY-SA
Subscribe to rss feed
In an 11-year study, researchers at the National Institutes of Health have further characterized idiopathic CD4 lymphocytopenia (ICL), a rare immune deficiency that leaves people vulnerable to infectious diseases, autoimmune ...
May 3, 2023
0
6
A majority of parents of children diagnosed with Lyme disease reported that their kids recovered within six months of completing antibiotic treatment, according to a new joint study from Children's National Research Institute ...
Apr 21, 2023
0
37
In November 2022, the National Institute of Allergy and Infectious Diseases (NIAID) co-hosted a virtual workshop on the importance and challenges of developing mucosal vaccines for SARS-COV-2. The highlights of this workshop ...
Apr 13, 2023
0
26
A National Institutes of Health (NIH) clinical trial was stopped early because a daily statin medication was found to reduce the increased risk of cardiovascular disease among people living with HIV in the first large-scale ...
Apr 11, 2023
0
45
The oral antibiotic doxycycline prevented the acquisition of sexually transmitted infections (STIs) when tested among men who have sex with men (MSM) and transgender women who took the medication within 72 hours of having ...
Apr 7, 2023
1
41
Scientists have identified an autoinflammatory disease caused by mutations in the LYN gene, an important regulator of immune responses in health and disease. Named Lyn kinase-associated vasculopathy and liver fibrosis (LAVLI), ...
Mar 28, 2023
0
38
A clinical trial testing a freeze-dried, temperature-stable experimental tuberculosis (TB) vaccine in healthy adults found that it was safe and stimulated both antibodies and responses from the cellular arm of the immune ...
Mar 6, 2023
0
98
Eliminating animal milk alone from the diet of adults with eosinophilic esophagitis (EoE) is as effective at treating the disease as eliminating animal milk plus five other common foods, a new clinical trial has found. For ...
Feb 27, 2023
0
57
A National Institutes of Health research group with extensive experience studying ebolavirus countermeasures has successfully developed a vaccine against Sudan virus (SUDV) based on the licensed Ebola virus (EBOV) vaccine. ...
Feb 3, 2023
0
67
A newly published paper in The Lancet shows that an experimental vaccine against Marburg virus (MARV) was safe and induced an immune response in a small, first-in-human clinical trial. The vaccine, developed by researchers ...
Jan 30, 2023
0
59
